Brussels, 11/09/2007 (Agence Europe) - In a press release published on Tuesday 11 September, the European Commission welcomed the first clinical trial of a novel avian influenza vaccine against the subtype H7N1. These preliminary results have shown that the product is safe and well tolerated in healthy volunteers. The vaccine was developed, from the design of the vaccine virus to the completion of this first clinical trial, by a team of European scientists and co-funded by the EU Research...